AO Spine Knowledge Forum Spinal Cord Injury (SCI)

Building on worldwide research partnerships for global impact

Goals

AO Spine Knowledge Forum Spinal Cord Injury at the GSC 2024 in Bangkok 2024 AO Spine KFSCI at the Global Spine Congress 2024 in Bangkok, Thailand.

The AO Spine KF SCI seeks to define new treatment approaches and address critical knowledge gaps to enhance outcomes for both traumatic and non-traumatic spinal cord injury patients by performing research projects that bring significant impact to the spine surgeon community. They will do this by addressing the following knowledge gaps:

  • Central cord pattern of incomplete tetraplegia in the setting of a mechanically stable cervical spine: what is the role of early surgery?
  • What tools could be used to better understand and characterize a cord injury? For example, MRI, intraoperative ultrasound?
  • What is the best way of achieving decompression?
  • What additional guidelines are necessary for surgeons treating SCI patients?
  • Filling the knowledge gaps in degenerative cervical myelopathy (DCM) through the AO Spine RECODE project.

Ongoing research projects

  • I SCRIBBLE – The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation Study

    PCI: Brian Kwon / Co-PCI: Shekar Kurpad, Lukas Grassner

    Goals: The primary objective of this study is to determine the accuracy of serum NF-L and GFAP levels (i.e., the biomarkers) at different time points postinjury for predicting the severity of neurologic impairment at 6 months postinjury as either motor complete (AIS grade A/B) or motor incomplete (AIS grade C/D).

  • 2022 AO Spine Discovery and Innovation Award: Simultaneous functional MRI assessment of cervical spinal cord and brain activity in degenerative cervical myelopathy

    PI: Andrew H. Milby

    Goals: The goal of this study is to investigate the correlation between altered spinal cord and brain activity patterns and the severity of the disease in patients with Cervical Spondylotic Myelopathy (CSM). The study aims to determine whether these altered activity patterns can predict disease progression and provide critical information to better guide treatment decision-making for CSM patients.

  • 2022 AO Spine Knowledge Forum Associated Research Award: The Degenerative Cervical Myelopathy – Subjective and Objective Score (DCM-SOS), a Novel Outcome Measure

    PI: Allan R. Martin

    Goal: The goal of this study is to develop the Degenerative Cervical Myelopathy Subjective and Objective Score (DCM-SOS). The DCM-SOS is intended to improve upon the mJOA by introducing more detailed scoring, additional questions, and objective physical tests. This tool aims to offer an accurate and reliable assessment of neurological dysfunction in degenerative cervical myelopathy (DCM) in under 10 minutes, without requiring specialized equipment.

  • 2024 AO Spine Knowledge Forum Associated Research Award: Plasma proteomics-based biomarker discovery for degenerative cervical myelopathy

    PI: Aditya Vedantam

    Goal: To identify a blood-based protein biomarker for diagnosis in DCM. For this purpose, an unbiased plasma proteomics to assess the circulating proteome before and after surgery will be used.

  • SCIPOEM

    Prognostic Factors and Therapeutic Effects of Surgical Treatment for Traumatic Spinal Column Injury with Spinal Cord Injury: A Prospective, Observational European Multi-center Study.

    PCI: Dr. Allard J.F. Hosman

    Co-PCI: Dr. Giuseppe Barbagallo, MD, Dr. Joost J. van Middendorp

    Goals: The SCI-POEM is a prospective, observational multicenter cohort study to evaluate the effectiveness of early surgical treatment among patients with a traumatic spinal column injury. More specifically, the (1) neurological, (2) functional and (3) treatment complications outcomes will be compared between SCI patients with early (≤ 12 hours after the tSCI) and late (> 12 hours and < 14 days after the tSCI) surgical spinal decompression.

  • AO Spine RECODE-DCM ACT for NOW

    AO Spine RECODE DCM 2.0 Acelerating Creation and Translation of kNOWledge for Degenerative Cervical Myelopathy“

    PI: Benjamin Davies

    Goals: RECODE DCM 2.0 is an extension of the RECODE-DCM 1.0 initiative, which identified the Top 10 Research Priorities—recognized as the most critical research questions in the field, defined an index term, and established a minimum dataset to standardize research and accelerate knowledge discovery. Building on this work and to maintain momentum, RECODE DCM 2.0 is being launched. RECODE 2DCM 2.0 includes seven projects, referred to as an “ACTs” (Accelerating Creation and Translation) to accelerate knowledge discovery and its translation into practice, with the aim of improving care for people living with DCM. The ultimate goal is to re-invigorate the multidisciplinary, global community and focus on knowledge to action strategies.

  • IN-TWIN

    Traumatic incomplete cervical tetraplegia without instability: a prospective multicenter feasibility study of outcomes and prognosis

    Principal investigator:

    Jefferson R. Wilson

    Co-Principal Investigator:

    Brian Kwon

    Goals:

    To determine the feasibility of collecting a set of outcomes assessing hand function, gait, spasticity, neuropathic pain, and quality of life in incomplete cervical spinal cord injury patients without spinal instability and conduct exploratory analysis. The results of this study will be used to plan a large prospective study with the ultimate goal of identifying the role of timing of surgery in the management of this patient group.

    INTWIN GOV Number: https://www.clinicaltrials.gov/study/NCT05653206?cond=instability%20cervical&rank=6

Completed research projects

  • AO Spine-Praxis Clinical Practice Guidelines

    Leadership team:

    Brian Kwon
    Michael Fehlings
    Nathan Evaniew
    Lindsay Tetreault

    Goals:

    To generate three clinical practice guidelines to implement evidence into practice. These guidelines will contain evidence-based recommendations intended to optimize the care of spinal cord injury (SCI) patients worldwide. The guideline topics include:

    1. Timing of surgical decompression (update of AO Spine guideline from 2017).
    2. Hemodynamic management of acute SCI (update from AANS/CNS guideline from 2013).
    3. Management of perioperative SCI (de novo guideline).

    Collaborators:

    Praxis Spinal Cord Injury Institute - https://praxisinstitute.org/
    Aggregate Analytics Inc.

  • AO Spine RECODE-DCM

    Principal investigator:

    Mark Kotter

    Co-Principal investigator:

    Benjamin Davies

    Goals:

    The AO Spine RECODE-DCM group created a ‘Research Toolkit’ to equip scientists with the tools to make their studies robust, comparable, and focused on the outcomes that matter most for people with Degenerative Cervical Myelopathy. To address the established research priorities, international special-interest ‘incubators’ (groups of clinicians, other healthcare professionals, and individuals with lived experience) were formed focusing on: Natural History, Diagnostic Criteria, and Peri-Operative Rehabilitation. These groups are led by Knowledge Forum representatives.

    To learn more and join the global community, please go here

  • 2022 AO Spine Discovery and Innovation Award: Validating neuro-navigated TMS stimulation in SCI patients: a feasibility study towards a gene therapy for SCI

    PI: Aminul Ahmed

    Goals: This was a feasibility study to compare the use of TransCranial Magnetic stimulation as an outcome measure when compared to the standard assessments used in the EM-SCI csriteria. The aim was to recruit a mix of patients across all ASIA grades and both cervical and thoracic injuries.

  • KFT SCI completed Database merge

    Combining data from two existing registries (NACTN and STASCIS)

    Principal investigator (PI):

    Michael Fehlings

    Goals:

    To combine two existing databases on patients with spinal cord injuries treated surgically (NACTN and STASCIS) and to assess descriptive data on injury/surgery details, as well as the ASIA score and complications reported

    Documents:

    Publication summary

  • SCI-DCM Guidelines

    Development of evidence-based clinical guidelines for the treatment of acute spinal cord injury (SCI)

    Principal investigator:

    Michael Fehlings

    Goals:

    A set of systematic reviews will deliver an understanding of the current state of the field. Based on this knowledge, a global team of clinical experts in SCI will then go through the rigorous process of developing evidence-based clinical guidelines for the treatment of acute spinal cord injury. Injury specific to the five selected topics:

    • Use of methylprednisolone
    • Timing of decompression
    • Role and timing of magnetic resonance imaging
    • Type and timing of anticoagulation
    • Type and timing of rehabilitation

    Note:

    Co-sponsored by AO Spine North America

    Documents:

    Guidelines Special Issue
    Publication summary

    Guidelines:

    Access the guidelines here

  • RISCIS

    A multi-center, randomized, placebo-controlled, double-blinded trial of the efficacy and safety of Riluzole in acute spinal cord injury

    Principal investigator (PI):

    Michael Fehlings

    Goals:

    Aims to evaluate the efficacy and safety of Riluzole in the treatment of patients with acute spinal cord injury. The primary objective is to evaluate the superiority of Riluzole, as compared to a placebo, in improving motor outcomes as measured by the ASIA Motor Score at six months follow-up, in patients with acute traumatic spinal cord injury, presenting to hospital less than 12 hours after injury.

    Note:

    Co-sponsored by AO Spine North America, US Department of Defense, Christopher and Dana Reeve Foundation, Ontario Neurotrauma Foundation, Rick Hansen Institute

    Documents:

    Publication summary

    ClinicalTrials.gov Identifier: NCT01597518

  • Modulation of Inflammatory Responses

    Modulation of Inflammatory Responses Using Neural Crest Derived Dental Pulp Stem Cells Following Acute Spinal Cord Injury

    Principal investigator:

    Ryan O’Hare Doig

    Co-Principal investigators:

    Brian James, Christopher Freeman, Stan Gronthos

    Goals:

    Aims to develop a better understanding of the pathophysiological pathways and effects of stem cell distribution, survival and differentiation, following spinal cord injury using advanced imaging and labelling techniques

    Outcome:

    The Translation of Nanomedicines in the Contexts of Spinal Cord Injury and Repair - PMC

KF Spinal Cord Injury (SCI) Steering Committee

Shekar Kurpad
Chairperson
Froedtert & the Medical College of Wisconsin
Milwaukee, USA

Brian Kwon
Past Chairperson
University of British Columbia
Vancouver, Canada

Jefferson Wilson
University of Toronto
Division of Neurosurgery
Toronto, Canada

L Grassner

Lukas Grassner
Paracelsus Medical University
Salzburg, Austria

Allan R Martin

Allan R. Martin
University of California
Davis, CA, USA

Ricardo Rodrigues-Pinto

Ricardo Rodrigues-Pinto
University of Porto
Porto, Portugal

KF Spinal Cord Injury (SCI) Advisory Board

Bizhan Aarabi
University of Maryland
Baltimore, USA

James Harrop
Thomas Jefferson University
Philadelphia, USA

Michael Fehlings
University of Toronto
Toronto, Canada

Mark Kotter
University of Cambridge
Cambridge, UK

James Guest
University of Miami
Miami, USA

Vafa Rahimi-Movaghar
Sina Trauma and Surgery Research Center
Tehran University of Medical Sciences
Tehran, Iran

KF SCI Associate Members

Benjamin Davies, University of Cambridge, Cambridge, UK
Ryan O’Hare Doig, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
Nathan Evaniew, Foothills Medical Centre, University of Calgary, Calgary, AB, Canada
Farzin Farahbakhsh, Tehran University of Medical Sciences, Tehran, Iran
Mario Ganau, Oxford University Hospitals NHS Foundation Trust, Oxford, UK 
Yoon Ha, Severance Hospital College of Medicine, Yonsei University, Seoul, Korea
Christoph Hofstetter, University of Washington, Seattle, WA, USA
Rex Marco, Houston Methodist Hospital, Houston, TX, USA
Paul Koljonen, Queen Mary Hospital, The University of Hong Kong, China
Hiroaki Nakashima, Nagoya University Graduate School of Medicine, Aichi, Japan
Chris Neal, Walter Reed National Military Medical Center-Bethesda, Bethesda, MD, USA
Lindsay Tetreault, NYU Langone Health, New York, NY, USA
Aditya Vedantam, Medical College of Wisconsin, Milwaukee, WI, USA 
Paula Valerie ter Wengel, Haaglanden Medisch Centrum, Haaglanden, Netherlands
Anthony DiGiorgo, University of California, San Francisco, CA, USA 
Aria Nouri, Geneva University Hospitals, Geneva, Switzerland
Aminul Ahmed, King's College London, London, UK
Andrew Milby, Emory University, Atlanta, GA, USA
Daipayan (Deep) Guha, McMaster University Hamilton, ON, Canada
Konstantinos Margetis, The Mount Sinai Hospital New York, USA
David B. Anderson, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
Vanessa Hubertus, Charité - Universitätsmedizin Berlin, Berlin, Germany
Jetan H. Badhiwala, Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Canada
Paul Arnold, Loyola University Medical Center, Chicago, USA
Nader Hejrati, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
Nitin Agarwal, University of Pittsburgh Medical Center, Department of Neurological Neurosurgery, Pittsburgh, PA, USA

 

Knowledge Forum Manager

Marije de Jong

Marije de Jong

Project Manager

Other Knowledge Forums

AO Spine KF Tumor

AO Spine KF Deformity

AO Spine KF Degenerative

AO Spine KF Trauma and Infection

“We are defining critical knowledge gaps that represent areas of research in the future. We’d like to see this lead to changes in clinical practice, improved outcomes, and changes in society with better access to care.”

Michael Fehlings